by Jordana Choucair | Sep 29, 2021 | Payers
According to the Business Roundtable, Democrats’ proposed corporate tax hike is one of the greatest threats to companies’ investment, hiring, and growth plans in the foreseeable future. The organization’s latest survey showed that CEOs have three primary concerns:...
by Jordana Choucair | Sep 29, 2021 | Opioid/Substance Use Disorders
The Cherokee Nation reached a $75 million settlement with opioid distributors McKesson Corp., Cardinal Health Inc., and AmerisourceBergen Corp. to resolve claims that the companies fueled prescription opioid abuse within the tribe. The settlement, the largest in...
by Jordana Choucair | Sep 29, 2021 | Life Sciences
Americans who have received a third COVID-19 shot reported similar rates of side effects as they did after their second doses. According to CDC data through mid-September, most symptoms were mild to moderate, suggesting the extra shots are safe. (Articles here and...
by Jordana Choucair | Sep 29, 2021 | D.C. News
Centrist Democrats are weighing whether new Medicare benefits should go only to lower-income Americans as they look for ways to cut the cost of their party’s sweeping domestic spending bill. Senator Joe Manchin and Representative Henry Cuellar have said benefits need...
by Jordana Choucair | Sep 28, 2021 | M&A
The FTC has requested information regarding the Spectrum-Beaumont hospital system merger in Michigan. The two hospital systems said they are responding to the request and that a surge of merger filings is holding up the regulatory review of their proposed deal. Should...
by Jordana Choucair | Sep 28, 2021 | Life Sciences
Pfizer and BioNTech submitted data to the FDA on their COVID-19 vaccine for children ages 5 to 11. The companies said that they would formally ask within weeks that the shot be authorized for children in that age group. If regulators follow the same timeline they took...
Recent Comments